Evidence map›Paper›PMID 9111340›Full record

ArticleMolecular and cellular biology1997

Coding elements in exons 2 and 3 target c-myc mRNA downregulation during myogenic differentiation.

N M Yeilding, W M Lee

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. RNA-cleaving properties of human apurinic/apyrimidinic endonuclease 1 (APE1).International journal of biochemistry and molecular biology · 2010
    Article
  6. Article
  7. Article
  8. Feedback regulation of c-Myc by ribosomal protein L11.Cell cycle (Georgetown, Tex.) · 2007
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

N M YeildingDepartment of Medicine and Cancer Center, University of Pennsylvania, Philadelphia 19104, USA.
W M Lee
University of Pennsylvania · US

Funding

DETERMINANTS OF C-MYC MRNA EXPRESSION IN C2 MYOBLASTSF32GM016261 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI YEILDING, NEWMAN M · 1993 to 1994
–
POSTTRANSCRIPTIONAL REGULATION OF C-MYC IN C2 MYOBLASTSK08AR001956 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI YEILDING, NEWMAN M · 1995 to 1999
–
POSTTRANSCRIPTIONAL REGULATION OF C-MYC MRNAR01GM047147 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI LEE, WILLIAM M · 1992 to 1995
–
NIAMS NIH HHS AR01956NIGMS NIH HHS GM16261-01NIGMS NIH HHS GM47147
6 · The paper itself

Abstract

Downregulation in expression of the c-myc proto-oncogene is an early molecular event in differentiation of murine C2C12 myoblasts into multinucleated myotubes. During differentiation, levels of c-myc mRNA decrease 3- to 10-fold despite a lack of change in its transcription rate. To identify cis-acting elements that target c-myc mRNA for downregulation during myogenesis, we stably transfected C2C12 cells with mutant myc genes or chimeric genes in which various myc sequences were fused to the human beta-globin gene or to the bacterial chloramphenicol acetyltransferase (CAT) gene. Deletion of coding sequences from myc exon 2 or exon 3 abolished downregulation of myc mRNA during myogenic differentiation, while deletion of introns or sequences in the 5' or 3' untranslated regions (UTRs) did not, demonstrating that coding elements in both exons 2 and 3 are necessary for myc mRNA downregulation. Fusion of coding sequences from either myc exon 2 or 3 to beta-globin mRNA conferred downregulation onto the chimeric mRNA, while fusion of myc 3' UTR sequences or coding sequences from CAT or ribosomal protein L32 did not, demonstrating that coding elements in myc exons 2 and 3 specifically confer downregulation. These results present the apparent paradox that coding elements in either myc exon 2 or myc exon 3 are sufficient to confer downregulation onto beta-globin mRNA, but neither element alone was sufficient for myc mRNA downregulation, suggesting that some feature of beta-globin mRNA may potentiate the regulatory properties of myc exons 2 and 3. A similar regulatory function is not shared by all mRNAs because fusion of either myc exon 2 or myc exon 3 to CAT mRNA did not confer downregulation onto the chimeric mRNA, but fusion of the two elements together did. We conclude from these results that two myc regulatory elements, one exon 2 and one in exon 3, are required for myc mRNA downregulation. Finally, using a highly sensitive and specific PCR-based assay for comparing mRNA levels, we demonstrated that the downregulation mediated by myc exons 2 and 3 results in a decrease in cytoplasmic mRNA levels, but not nuclear mRNA levels, indicating that regulation is a postnuclear event.

Indexed as

Down-RegulationAnimalsCell DifferentiationChloramphenicol O-AcetyltransferaseExonsGlobinsMiceMusclesProto-Oncogene MasProto-Oncogene Proteins c-mycRegulatory Sequences, Nucleic AcidRepetitive Sequences, Nucleic AcidRNA, MessengerSequence DeletionChloramphenicol O-AcetyltransferaseGlobinsMAS1 protein, humanProto-Oncogene MasProto-Oncogene Proteins c-mycRNA, Messenger

Identifiers

PMID9111340
PMCPMC232120
OpenAlexW2130364578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.